| Title |
Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism
|
|---|---|
| Published in |
Cell Reports, October 2019
|
| DOI | 10.1016/j.celrep.2019.09.056 |
| Pubmed ID | |
| Authors |
Alex J. Bott, Jianliang Shen, Claudia Tonelli, Le Zhan, Nithya Sivaram, Ya-Ping Jiang, Xufen Yu, Vrushank Bhatt, Eric Chiles, Hua Zhong, Sara Maimouni, Weiwei Dai, Stephani Velasquez, Ji-An Pan, Nathiya Muthalagu, Jennifer Morton, Tracy G. Anthony, Hui Feng, Wouter H. Lamers, Daniel J. Murphy, Jessie Yanxiang Guo, Jian Jin, Howard C. Crawford, Lanjing Zhang, Eileen White, Richard Z. Lin, Xiaoyang Su, David A. Tuveson, Wei-Xing Zong |
| Abstract |
Glutamine is thought to play an important role in cancer cells by being deaminated via glutaminolysis to α-ketoglutarate (aKG) to fuel the tricarboxylic acid (TCA) cycle. Supporting this notion, aKG supplementation can restore growth/survival of glutamine-deprived cells. However, pancreatic cancers are often poorly vascularized and limited in glutamine supply, in alignment with recent concerns on the significance of glutaminolysis in pancreatic cancer. Here, we show that aKG-mediated rescue of glutamine-deprived pancreatic ductal carcinoma (PDAC) cells requires glutamate ammonia ligase (GLUL), the enzyme responsible for de novo glutamine synthesis. GLUL-deficient PDAC cells are capable of the TCA cycle but defective in aKG-coupled glutamine biosynthesis and subsequent nitrogen anabolic processes. Importantly, GLUL expression is elevated in pancreatic cancer patient samples and in mouse PDAC models. GLUL ablation suppresses the development of KrasG12D-driven murine PDAC. Therefore, GLUL-mediated glutamine biosynthesis couples the TCA cycle with nitrogen anabolism and plays a critical role in PDAC. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 9 | 29% |
| France | 3 | 10% |
| Canada | 2 | 6% |
| Germany | 1 | 3% |
| Austria | 1 | 3% |
| United Kingdom | 1 | 3% |
| Mexico | 1 | 3% |
| Korea, Republic of | 1 | 3% |
| Italy | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 11 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 14 | 45% |
| Members of the public | 11 | 35% |
| Science communicators (journalists, bloggers, editors) | 4 | 13% |
| Practitioners (doctors, other healthcare professionals) | 2 | 6% |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 152 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 23 | 15% |
| Researcher | 19 | 13% |
| Student > Bachelor | 12 | 8% |
| Student > Master | 12 | 8% |
| Professor | 5 | 3% |
| Other | 18 | 12% |
| Unknown | 63 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 39 | 26% |
| Agricultural and Biological Sciences | 14 | 9% |
| Medicine and Dentistry | 12 | 8% |
| Chemistry | 6 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Other | 11 | 7% |
| Unknown | 65 | 43% |